Repligen Corporation

NASDAQ:RGEN

Medical - Instruments & Supplies

Healthcare
$172.67 -2.74%

-$3.66 today

Market cap
$11.04B
Beta
1.08
P/E (TTM)
142.4
EPS (TTM)
$0.91
52W Low $100.99High $175.77

Volume 1.30M

Average 1.08M

RGEN Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Repligen CorporationNASDAQ: RGEN

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q2 FY2026 weighted avg shares (diluted) of 56.66M shares rose 0.3% year over year, in line with the +0.1% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 0.0% from the prior quarter. Over 3 fiscal years it compounded at -0.5% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +0.3% holds above the trailing-twelve-month pace of +0.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
56.66M-0.0% QoQ
Last fiscal yearDec 2025
56.56M+1.1% YoY
LTMJun 2026
56.59M+0.1% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.3%——
1 year+1.1%——
3-year CAGR-0.5%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
56.56M USD
Year-over-year change
+1.1%
4-year CAGR
-0.3%

Weighted Avg Shares (Diluted) vs competitors

How RGEN compares with its peers on the latest reported figures

  • RGEN's LTM Jun 2026 weighted avg shares (diluted) of 56.59M shares is the 7th highest of the 9 companies compared; the peer median is 183.98M shares.
  • Its year-over-year change of +0.1% is the 3rd highest of 9, against a peer median of -0.8%.
  • Over three fiscal years its annual growth of -0.5% compares with a peer median of -1.2%.
RGEN Competitors Peer median
Weighted Avg Shares (Diluted) for RGEN and competitors
Company Period LTM YoY 3-year CAGR
AVTRAvantor, Inc.LTM Jun 2026679.38M -0.5%-0.0%
TMOThermo Fisher Scientific Inc.LTM Sep 2026373M -1.7%-1.5%
AAgilent Technologies, Inc.LTM Jul 2026283.75M -1.1%-1.8%
QGENQiagen N.V.LTM Jun 2026210.75M -4.3%-2.3%
TECHBio-Techne CorporationLTM Sep 2026157.22M -0.4%-1.0%
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026146.04M +2.7%+3.3%
RGENRepligen CorporationLTM Jun 202656.59M +0.1%-0.5%
BLFSBioLife Solutions, Inc.LTM Mar 202648.6M +3.8%+4.6%
BIOBio-Rad Laboratories, Inc.LTM Jun 202626.93M -3.1%-2.9%
Peer median (excluding RGEN) 183.98M-0.8%-1.2%

Competitors are the stored peer set for RGEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue670.53M801.54M632.36M634.44M738.26M
Cost of Revenue279.28M345.83M353.92M359.79M390.63M
Gross Profit391.25M455.71M278.44M274.65M347.62M
Gross Margin58.3%56.9%44.0%43.3%47.1%
Research & Development34.27M43.94M42.72M43.2M54.18M
Selling, General & Admin183.87M215.83M218.58M263.37M290.51M
Operating Expenses224.01M231.04M230.74M309.76M288.05M
Depreciation & Amortization38.45M57.01M86.11M86.56M96.96M
EBITDA203.27M277.31M145.32M80.26M182.51M
EBITDA Margin30.3%34.6%23.0%12.7%24.7%
Operating Income167.25M224.67M47.7M(35.11M)59.58M
Operating Margin24.9%28.0%7.5%-5.5%8.1%
Interest Income176K6.98M0027.57M
Interest Expense12.71M2.98M10.03M22.57M23.17M
Other Income / Expenses(13.71M)(5.53M)9M8.08M2.81M
Income Before Tax153.54M219.14M56.71M(27.04M)62.38M
Pre-Tax Margin22.9%27.3%9.0%-4.3%8.5%
Income Tax Expense25.25M33.18M21.11M(1.52M)13.49M
Net Income128.29M185.96M35.6M(25.51M)48.89M
Net Margin19.1%23.2%5.6%-4.0%6.6%
EPS (Basic)2.333.350.64(0.46)0.87
EPS (Diluted)2.243.240.63(0.46)0.86
Weighted Avg Shares55.02M55.46M55.72M55.94M56.23M
Weighted Avg Shares (Diluted)57.26M57.46M56.38M55.94M56.56M

Repligen Corporation

NASDAQ:RGEN

Intrinsic Alpha fair value

Locked

Current Price

$172.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.